PANACEABIO

Panacea Biotec Ltd.

NSE: PANACEABIO

BSE: 531349

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

350.00-9.0 (-2.52%)

5 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

35.9 / 100

Value Score

16.7 / 100

Price Momentum Score

38.4 / 100

QVM Score

12.5 / 100

Key Metrics

Market Cap

2143.78

P/E (TTM)

P/B

2.57

P/S (TTM)

3.19

EV/EBITDA

928.21

CAPE (5Y)

9.85

ROE (TTM)

-0.64

ROCE (TTM)

-4.42

ROA (TTM)

-0.42

Avg 3Y ROE

-0.59

Earnings 3Y CAGR

-30.25

Sales 3Y CAGR

12.03

Sales 5Y CAGR

1.50

Debt/Equity

0.03

Consensus TP

Strong Buy %

Promoter Holding

72.48

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Panacea Biotec Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Low Debt to Equity, not much change from last year

The company has low Debt to Equity of 0.03 as on 30 Jun 2026 and Debt to Equity remained same in the last 1 year

What is Debt to Equity?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Stock is fairly expensive with negative EPS on a trailing 12-month basis

Earnings yield of -0.34% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis

What is Earnings yield (E/P)?

Low but stable ROE

The company reported low ROE of -0.64% for 12-month ended 30 Jun 2026 and ROE improved marginally by 36 bps from 1 year ago

What is ROE (FY)?

Low EPS growth and lower than median growth of industry

The company delivered moderate EPS growth of -162.52% for 12-month ended 30 Jun 2026 and the growth was 169.97 percentage points lower than median growth of industry

What is EPS growth (1Y)?

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Low operating margin but improving trend

The company reported low operating margin of -5.9% for 12-month ended 30 Jun 2026 but operating margin improved by 189 bps from 1 year ago

What is Operating profit margin?

Moderate revenue growth and in line with median growth of industry

The company delivered moderate revenue growth of 10.26% for 12-month ended 30 Jun 2026 and the growth was 0.42 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 10.68

Value 10.26

-99.6111701.8

Company's earnings are of moderate quality

Earnings quality score of 43.6 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

43.6 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Panacea Biotec Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Panacea Biotec Ltd. Shareholding Pattern

Quarterly breakdown of Panacea Biotec Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Promoter	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.46	72.87	72.49	72.48	72.48	72.48	72.48	72.48	72.48
Indian Promoter	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.59	73.46	72.87	72.49	72.48	72.48	72.48	72.48	72.48	72.48
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	1.61	1.28	1.33	1.39	1.37	0.45	0.42	0.13	0.00	0.00	0.43	0.61	0.61	0.76	0.83	0.95	1.11	1.34	1.53	1.54	2.65	2.30	2.86	3.21	3.57	4.56
Mutual Funds / UTI	1.60	1.28	1.28	1.28	1.27	-	-	-	-	-	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.05	0.05	0.10	0.03	0.02	0.00	0.00	0.00	0.14	0.18	0.18	0.22	0.26	0.26	0.27	0.26	0.37	0.38	1.16	0.79	1.06	1.36	1.60	2.31
Other Institutions	0.00	0.00	0.00	0.06	0.00	0.42	0.39	0.13	0.00	0.00	0.29	0.43	0.43	0.54	0.57	0.69	0.84	1.07	1.16	1.16	1.49	1.52	1.80	1.85	1.96	2.25
Non-Institution	24.79	25.13	25.08	25.02	25.04	25.95	25.99	26.28	26.41	26.41	25.98	25.80	25.80	25.66	25.58	25.46	25.30	25.20	25.60	25.97	24.87	25.22	24.66	24.31	23.96	22.96
Bodies Corporate	12.20	10.71	9.15	7.31	6.48	9.32	9.07	9.05	9.42	9.50	8.77	8.44	8.80	8.26	4.23	3.54	2.61	1.77	4.48	3.94	2.09	2.16	1.69	1.61	1.47	1.81
Others (incl. Retail) No. of shareholders	12.59 10,403	14.42 22,145	15.93 25,493	17.71 26,838	18.56 27,055	16.63 54,119	16.92 52,637	17.23 52,284	16.99 49,403	16.91 49,741	17.21 48,919	17.36 50,366	17.00 48,476	17.40 47,652	21.35 48,635	21.92 46,873	22.69 46,057	23.43 45,331	21.12 39,731	22.03 35,197	22.78 33,338	23.06 33,936	22.97 33,292	22.70 34,299	22.49 32,351	21.15 33,264

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

#	Index	Weight	Rank
1	SHI: Biotech	1.73%	15 / 15

Prominent Investor Holdings

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Panacea Biotec Ltd. shares as reported to NSE and BSE.

Name	Month	Transaction	Holding % pre transaction	Average price	Qty.	Transaction value
Nosheen Sheikh Employees Immediate Relative	October-2025	Market Purchase (Acquisition) 3rd Oct 2025	0.00 %	₹ 406.78	3.00 k	₹ 12.20 lac
Sandeep Jain Promoter & Director	January-2025	Market Sale (Disposal) 2nd Jan 2025	15.28 %	₹ 409.06	5.00 k	₹ 20.45 lac
Sandeep Jain Promoter & Director	January-2025	Market Sale (Disposal) 2nd Jan 2025	15.28 %	₹ 409.06	5.00 k	₹ 20.45 lac
Sandeep Jain Promoter & Director	December-2024	Market Sale (Disposal) 31st Dec 2024	15.29 %	₹ 425.04	10.00 k	₹ 42.50 lac
Rajesh Jain Director	December-2024	Market Purchase (Acquisition) 30th Dec 2024	0.00 %	₹ 454.90	3.00 k	₹ 13.65 lac
Sandeep Jain Promoter & Director	December-2024	Market Sale (Disposal) 25th Dec 2024	15.32 %	₹ 439.55	10.00 k	₹ 43.96 lac
Sandeep Jain Promoter & Director	December-2024	Market Sale (Disposal) 25th Dec 2024	15.30 %	₹ 426.23	5.00 k	₹ 21.31 lac
Sandeep Jain Promoter & Director	December-2024	Market Sale (Disposal) 20th Dec 2024	15.33 %	₹ 450.89	5.00 k	₹ 22.54 lac
Sandeep Jain Promoter & Director	December-2024	Market Sale (Disposal) 20th Dec 2024	15.33 %	₹ 455.32	5.70 k	₹ 25.95 lac
Sandeep Jain Promoter & Director	December-2024	Market Sale (Disposal) 17th Dec 2024	15.36 %	₹ 470.78	11.00 k	₹ 51.79 lac

…

Corporate Actions

History of Panacea Biotec Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Others
Ex-date: 21st Sep 2020Announced on: 14th Sep 2017
Demerger of real estate business into Ravinder Heights Limited. for preference shares 1 0.5% cumulative non convertible and non participating preference share f…
Dividend₹ 0.75/share
Record date: 20th Sep 2011Ex-date: 19th Sep 2011
Announced on: 13th May 2011
Dividend₹ 0.25/share
Record date: 18th Sep 2010Ex-date: 16th Sep 2010
Announced on: 7th May 2010
Dividend₹ 1/share
Record date: 23rd Sep 2008Ex-date: 19th Sep 2008
Announced on: 26th Jun 2008
Dividend₹ 1/share
Record date: 25th Sep 2007Ex-date: 21st Sep 2007
Announced on: 14th Jun 2007

Company Profile

Overview of Panacea Biotec Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Panacea Biotec Limited is an India-based pharmaceutical and biotechnology company with research, manufacturing and marketing capabilities. The Company is engaged in the business of research, development, manufacture and marketing of branded vaccines, pharmaceutical formulations, nutraceuticals and f...

Key personnel

Mr. Vinod Goel

Group Chief Financial Officer, Head Legal & Corporate Governance

Dr. Rajesh JainD

Executive Chairman of the Board, Managing Director

Mr. Ankesh JainD

Compliance Officer, Executive Director, Company Secretary

Mr. Sandeep JainD

Joint Managing Director, Executive Director

Mr. Harshet JainD

Whole Time Director

Dr. Sanjay TrehanD

Director - Technical & Compliances

Mr. Krishan Kumar JalanD

Non-Executive Independent Director

Mr. Rajinder Singh MankuD

Additional Non-Executive Independent Director

View all

Incorporated on

02 Feb 1984

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

1,149

IPO date

25 Sep 1995

Free Float

1,48,09,292

Website

https://www.panaceabiotec.com/

Phone no.

+911141679000

Address

B-1 EXTN./ G-3, MOHAN CO-OPERATIVE INDUSTRIAL ESTATE, MATHURA ROAD, , 110044, India

Frequently Asked Questions

What is the current share price of Panacea Biotec Ltd.?

The current share price of Panacea Biotec Ltd. is ₹ 350.00 as of 5 Oct 2026.

What is the market capitalisation of Panacea Biotec Ltd.?

The market capitalisation of Panacea Biotec Ltd. stands at ₹ 2,143.78 Cr.

What is the PE ratio of Panacea Biotec Ltd.?

The Price-to-Earnings (PE) ratio of Panacea Biotec Ltd. is - as of the latest trailing twelve months data.

What is the ROE and ROCE of Panacea Biotec Ltd.?

Panacea Biotec Ltd. has a Return on Equity (ROE) of -0.64% and a Return on Capital Employed (ROCE) of -4.42% as per the latest financial reports.

What is the 52-week high and low of Panacea Biotec Ltd.?

The 52-week high of Panacea Biotec Ltd. is - and the 52-week low is -.

What is the dividend yield of Panacea Biotec Ltd.?

The dividend yield of Panacea Biotec Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Panacea Biotec Ltd.?

Foreign Institutional Investors (FII) hold 2.31%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 21.15% of Panacea Biotec Ltd. shares.

What sector does Panacea Biotec Ltd. belong to?

Panacea Biotec Ltd. operates in the Healthcare sector.

What is the beta of Panacea Biotec Ltd.?

The beta of Panacea Biotec Ltd. is 1.03, indicating its price volatility relative to the broader market. Over the past 1 year, Panacea Biotec Ltd. has delivered an absolute return of -16.62%.

What is the RSI of Panacea Biotec Ltd.?

The 14-day Relative Strength Index (RSI) of Panacea Biotec Ltd. is 33.61, placing it approaching oversold territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Panacea Biotec Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Panacea Biotec Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Corporate Actions

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Corporate Actions

Company Profile